ArticleMedicine2020

Concomitant fulvestrant with reirradiation for unresectable locoregional recurrent estrogen receptor positive (ER+) breast cancer: A case report and narrative review.

Jingxian Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.